API
API
API
MN Pharmaceuticals
FDA Logosu

Active Pharmaceutical Ingredients Plant

The Active Pharmaceutical Ingredients Plant (API) of MN Pharmaceuticals is established on an area of 60.000 m2 with a closed area of 15.000 m2, with its specialist team consisting of 100 people, and state-of-art premises, in Şekerpınar, Çayırova - Kocaeli.

On this area, there are four seperate API Production Units, a quality control laboratory, a research and development laboratory, a small scale production unit, a waste water treatment facility and utilities.

In four separate production units of the Active Pharmaceutical Ingredients Plant, penicillin group active substances, macrolide group active substances and etodolac and other active substances are manufactured.

In November 2006, the API Plant has been inspected and approved by FDA. In June 2009, API Plant has been inspected and approved for the second time by FDA.

In January 2009, following the certification investigation studies conducted by Turkish Standards Institute, Active Pharmaceutical Ingredients Plant has been awarded the Environment Management Systems Certificate in the scope of TSE ISO 14001 Standarts.